Literature DB >> 29991542

Mixed extragonadal germ cell tumour of the prostate.

Hugo Pontes Antunes1, Rui Almeida2, Vítor Sousa2, Arnaldo Figueiredo1.   

Abstract

Extragonadal germ cell tumours (EGGCTs) originated in prostate are extremely rare, with <20 cases described in the literature. We report a case of a patient with a primary prostatic mixed EGGCT. A 47-year-old man presenting severe low urinary tract symptoms and signs of prostatic enlargement, with no malignancy suspicion, underwent transurethral resection of the prostate. The histopathological evaluation suggested the diagnosis of a retroperitoneal sarcoma. The patient underwent neoadjuvant chemotherapy and then was submitted to radical cystoprostatectomy. Histology revealed a mixed EGGCT of the prostate with yolk sac tumour and seminoma components. No testicular abnormalities were identified on the postoperative scrotal ultrasound. The patient went through four cycles of chemotherapy with bleomycin, etoposide and cisplatin. After 12 months of follow-up, the patient is alive and free of recurrence. © Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer intervention; pathology; prostate; urinary and genital tract disorders; urological cancer

Mesh:

Substances:

Year:  2018        PMID: 29991542      PMCID: PMC6047698          DOI: 10.1136/bcr-2017-223603

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Extragonadal germ cell tumor of the prostate.

Authors:  B Kleinhans; T Kalem; D Hendricks; H Arps; T Kaelble
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

2.  Extragonadal germ cell tumor of the prostate associated with Klinefelter's syndrome.

Authors:  K Namiki; A Tsuchiya; K Noda; H Oyama; K Ishibashi; H Kusama; M Furusato
Journal:  Int J Urol       Date:  1999-03       Impact factor: 3.369

3.  Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.

Authors:  J T Hartmann; S D Fossa; C R Nichols; J P Droz; A Horwich; A Gerl; J Beyer; J Pont; K Fizazi; H Hecker; L Kanz; L Einhorn; C Bokemeyer
Journal:  J Natl Cancer Inst       Date:  2001-11-21       Impact factor: 13.506

4.  Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.

Authors:  Carsten Bokemeyer; Craig R Nichols; Jean-P Droz; Hans-J Schmoll; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Lothar Kanz; Lawrence Einhorn; Jörg T Hartmann
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

5.  Long-term mortality in patients with germ cell tumors: effect of primary cancer site on cause of death.

Authors:  Shaheen R Alanee; Darren R Feldman; Paul Russo; Badrinath Konety
Journal:  Urol Oncol       Date:  2013-02-12       Impact factor: 3.498

6.  Extragonadal retroperitoneal germ cell tumor: evidence of origin in the testis.

Authors:  M Scholz; M Zehender; G N Thalmann; M Borner; H Thöni; U E Studer
Journal:  Ann Oncol       Date:  2002-01       Impact factor: 32.976

Review 7.  Primary retroperitoneal soft tissue sarcoma: Imaging appearances, pitfalls and diagnostic algorithm.

Authors:  C Messiou; E Moskovic; D Vanel; C Morosi; R Benchimol; D Strauss; A Miah; H Douis; W van Houdt; S Bonvalot
Journal:  Eur J Surg Oncol       Date:  2016-12-09       Impact factor: 4.424

Review 8.  Extragonadal germ cell tumors: clinical presentation and management.

Authors:  Costantine Albany; Lawrence H Einhorn
Journal:  Curr Opin Oncol       Date:  2013-05       Impact factor: 3.645

9.  Primary extragonadal germ cell tumor of the prostate in a young man.

Authors:  PatricK J Bastian; Dirk Skowasch; Gerhard Bauriedel; Peter Behrens; Stefan C Muller; Peter Albers
Journal:  Int J Urol       Date:  2004-08       Impact factor: 3.369

10.  Mixed extragonadal germ cell tumor arising from the prostate: a rare combination.

Authors:  Shu-Guang Liu; Bin Lei; Xue-Nong Li; Xiao-Dong Chen; Shuang Wang; Lin Zheng; Hai-Li Zhu; Pei-Xin Lin; Hong Shen
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.